- Home
- Software Solutions
- Resources
- Corporate
A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids
Sponsors:
| Phases:
| |
| Indications | Acronym: MILLY | |
| ||
Age Groups:
| Gender: Both | |
Names:
| Enrollment: 200 | |
Additional information about NCT00930163.